-
1دورية أكاديمية
المؤلفون: Climent, Miguel A.1 (AUTHOR) macliment@fivo.org, Font, Albert2 (AUTHOR) afont@iconcologia.net, Durán, Ignacio3 (AUTHOR) ignacioduranmartinez@gmail.com, Puente, Javier4 (AUTHOR) jpuente.hcsc@salud.madrid.org, José Méndez-Vidal, María5 (AUTHOR) mjosemv@yahoo.es, Sáez, María Isabel6 (AUTHOR) msaez.med@gmail.com, Santander Lobera, Carmen7 (AUTHOR) csantlob@yahoo.es, Ángel Arranz Arija, Jóse8 (AUTHOR) jarranza.oncomed@gmail.com, González-del-Alba, Aranzazu9 (AUTHOR) aranglezalba@yahoo.es, Sánchez-Hernandez, Alfredo10 (AUTHOR) asanchezh@seom.org, Juan Fita, Maria Jose1 (AUTHOR) mjjuan@fivo.org, Esteban, Emilio11 (AUTHOR) eestebang@seom.org, Alonso-Gordoa, Teresa12 (AUTHOR) talonso@oncologiahrc.com, Mellado Gonzalez, Begoña13 (AUTHOR) bmellado@clinic.cat, Maroto, Pablo14 (AUTHOR) jmaroto@santpau.cat, Lázaro-Quintela, Martín15 (AUTHOR) martin.lazaro.quintela@sergas.es, Cassinello-Espinosa, Javier16 (AUTHOR) jacaes@sescam.jccm.es, Pérez-Valderrama, Begoña17 (AUTHOR) bperezv@gmail.com, Garcias, Carmen18 (AUTHOR) mariad.garcias@ssib.es, Castellano, Daniel19 (AUTHOR) cdanicas@hotmail.com
المصدر: European Journal of Cancer. Nov2022, Vol. 175, p110-119. 10p.
مصطلحات موضوعية: *DISEASE progression, *CONFIDENCE intervals, *ORAL drug administration, *METASTASIS, *ABIRATERONE acetate, *ANTINEOPLASTIC agents, *TREATMENT effectiveness, *RANDOMIZED controlled trials, *COMPARATIVE studies, *DOCETAXEL, *DESCRIPTIVE statistics, *PREDNISONE, *PROGRESSION-free survival, *PATIENT safety, *PHARMACODYNAMICS
-
2دورية أكاديمية
المؤلفون: Climent, Miguel Ángel1 macliment@fivo.org, Pérez-Valderrama, Begoña2, Mellado, Begoña3, Fernández Parra, Eva María4, Fernández Calvo, Ovidio5, Ochoa de Olza, María6, Muinelo Romay, Laura7, Anido, Urbano8, Domenech, Montserrat9, Hernando Polo, Susana10, Arranz Arija, José Ángel11, Caballero, Cristina12, Juan Fita, María José1, Castellano, Daniel13
المصدر: European Journal of Cancer. Dec2017, Vol. 87, p30-37. 8p.
مصطلحات موضوعية: *DOCETAXEL, *CLINICAL trials, *DRUG toxicity, *LEUCOPENIA, *NEUTROPENIA, *PREDNISONE, *PROSTATE tumors, *SURVIVAL, *THROMBOCYTOPENIA, *PROSTATE-specific antigen, *TREATMENT effectiveness, *CABAZITAXEL
-
3دورية أكاديمية
المؤلفون: Climent, Miguel Ángel, Torregrosa, M a Dolores, Vázquez, Sergio, Gironés, Regina, Arranz, José Angel, Torregrosa, Ma Dolores
المصدر: Cancer Treatment Reviews; Apr2017, Vol. 55, p173-180, 8p